Ireland's Lanas buys NZ health-tech firm indici in reported $100M-plus deal

What's the deal? Dublin-based Lanas has agreed to acquire indiciDealroom has a profile for this one. Try Dealroom →, a New Zealand provider of cloud-based electronic health record and practice management software. Terms were not disclosed, though media reporting suggests the transaction may exceed US$64.7M. The deal is subject to New Zealand regulatory approval.

What does indici do? It supplies software covering electronic health records, e-prescribing, telehealth, population health, and patient engagement. The platform serves more than 250 healthcare organisations and around two million patient records, making it the market's second-largest general-practice platform behind Medtech.

Why now? The acquisition is the first step in Lanas' pledge to invest US$97.1M in New Zealand's healthcare technology sector over two years, with total local investment expected to approach US$129.4M.

What's the endgame? Lanas, majority-owned by TA AssociatesDealroom has a profile for this one. Try Dealroom →, builds and buys healthcare technology spanning primary care, pharmacy, and specialist settings. It already owns HealthLinkDealroom has a profile for this one. Try Dealroom →, Toniq, and KonnectNET in New Zealand; indici adds a direct foothold in general-practice software.

"This is an important transaction for Lanas and a significant step in our long-term commitment to New Zealand's healthcare technology sector," said Ronan Lennon, chief legal officer at Lanas.

And Lanas is not done: it has indicated it is considering another local acquisition.

The signal: The deal extends a wave of consolidation in digital health software, as providers chase broader product ranges and larger customer bases. It also reflects continued overseas interest in established New Zealand software firms with embedded, long-term customer relationships.

Read more: itbrief.co.nz

Image credit: Generated with Gemini